Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China
· Delayed Price · Currency is CNY 22.47
-0.53 (-2.30%)
At close: Dec 5, 2025
SHE:002317 Revenue
Guangdong Zhongsheng Pharmaceutical had revenue of 589.02M CNY in the quarter ending September 30, 2025, with 8.35% growth. This brings the company's revenue in the last twelve months to 2.45B, up 0.04% year-over-year. In the year 2024, Guangdong Zhongsheng Pharmaceutical had annual revenue of 2.47B, down -5.48%.
Revenue (ttm)
2.45B
Revenue Growth
+0.04%
P/S Ratio
7.80
Revenue / Employee
1.38M
Employees
1,775
Market Cap
19.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.47B | -143.13M | -5.48% |
| Dec 31, 2023 | 2.61B | -65.60M | -2.45% |
| Jan 1, 2023 | 2.68B | 247.06M | 10.17% |
| Jan 1, 2022 | 2.43B | 533.27M | 28.13% |
| Dec 31, 2020 | 1.90B | -635.69M | -25.11% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| WuXi AppTec | 43.88B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Sichuan Biokin Pharmaceutical | 2.23B |
| Shanghai United Imaging Healthcare | 12.20B |
| Aier Eye Hospital Group | 22.17B |
| Zhangzhou Pientzehuang Pharmaceutical., | 9.78B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |